Neil Kumar's most recent trade in BridgeBio Pharma Inc was a trade of 18,923 Common Stock done at an average price of $71.0 . Disclosure was reported to the exchange on Feb. 19, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 71.03 per share. | 19 Feb 2026 | 18,923 | 243,581 (0%) | 0% | 71.0 | 1,344,190 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 72.08 per share. | 19 Feb 2026 | 8,528 | 235,053 (0%) | 0% | 72.1 | 614,702 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 72.80 per share. | 19 Feb 2026 | 602 | 234,451 (0%) | 0% | 72.8 | 43,826 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2026 | 33,544 | 262,320 (0%) | 0% | - | Common Stock | |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2026 | 33,544 | 134,176 | - | - | Restricted Stock Units | |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.25 per share. | 16 Feb 2026 | 30,970 | 262,504 (0%) | 0% | 75.3 | 2,330,493 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2026 | 19,600 | 281,920 (0%) | 0% | - | Common Stock | |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2026 | 19,600 | 156,794 | - | - | Restricted Stock Units | |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2026 | 11,554 | 293,474 (0%) | 0% | - | Common Stock | |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2026 | 11,554 | 138,645 | - | - | Restricted Stock Units | |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 71.80 per share. | 10 Feb 2026 | 14,201 | 701,485 (0%) | 0% | 71.8 | 1,019,657 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 71.80 per share. | 10 Feb 2026 | 14,040 | 4,504,407 (3%) | 0% | 71.8 | 1,008,006 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 70.70 per share. | 10 Feb 2026 | 7,860 | 4,490,587 (3%) | 0% | 70.7 | 555,706 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 70.69 per share. | 10 Feb 2026 | 7,806 | 687,880 (0%) | 0% | 70.7 | 551,796 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 72.27 per share. | 10 Feb 2026 | 5,960 | 4,498,447 (3%) | 0% | 72.3 | 430,751 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 72.28 per share. | 10 Feb 2026 | 5,799 | 695,686 (0%) | 0% | 72.3 | 419,165 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 72.63 per share. | 10 Feb 2026 | 4,484 | 679,680 (0%) | 0% | 72.6 | 325,695 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 72.65 per share. | 10 Feb 2026 | 4,404 | 4,482,408 (3%) | 0% | 72.6 | 319,938 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 73.25 per share. | 10 Feb 2026 | 3,994 | 675,686 (0%) | 0% | 73.3 | 292,574 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 73.25 per share. | 10 Feb 2026 | 3,961 | 4,478,447 (3%) | 0% | 73.3 | 290,145 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 71.46 per share. | 10 Feb 2026 | 3,775 | 4,486,812 (3%) | 0% | 71.5 | 269,754 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 71.44 per share. | 10 Feb 2026 | 3,716 | 684,164 (0%) | 0% | 71.4 | 265,477 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 73.65 per share. | 08 Jan 2026 | 11,565 | 4,546,882 (3%) | 0% | 73.7 | 851,811 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 73.64 per share. | 08 Jan 2026 | 11,515 | 744,171 (0%) | 0% | 73.6 | 848,018 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 77.46 per share. | 08 Jan 2026 | 10,677 | 4,520,302 (3%) | 0% | 77.5 | 827,016 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 77.61 per share. | 08 Jan 2026 | 10,519 | 716,061 (0%) | 0% | 77.6 | 816,365 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 74.38 per share. | 08 Jan 2026 | 8,135 | 4,538,747 (3%) | 0% | 74.4 | 605,061 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 74.38 per share. | 08 Jan 2026 | 8,085 | 736,086 (0%) | 0% | 74.4 | 601,340 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 76.72 per share. | 08 Jan 2026 | 6,955 | 726,580 (0%) | 0% | 76.7 | 533,569 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 76.53 per share. | 08 Jan 2026 | 6,067 | 4,530,979 (3%) | 0% | 76.5 | 464,289 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 75.75 per share. | 08 Jan 2026 | 2,151 | 733,535 (0%) | 0% | 75.8 | 162,943 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 78.10 per share. | 08 Jan 2026 | 1,855 | 4,518,447 (3%) | 0% | 78.1 | 144,882 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 75.61 per share. | 08 Jan 2026 | 1,401 | 4,537,046 (3%) | 0% | 75.6 | 105,928 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 75.16 per share. | 08 Jan 2026 | 400 | 735,686 (0%) | 0% | 75.2 | 30,064 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 78.19 per share. | 08 Jan 2026 | 375 | 715,686 (0%) | 0% | 78.2 | 29,322 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 75.20 per share. | 08 Jan 2026 | 300 | 4,538,447 (3%) | 0% | 75.2 | 22,561 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 60,975 | 289,751 (0%) | 0% | - | Common Stock | |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 60,975 | 60,976 | - | - | Restricted Stock Units | |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.15 per share. | 12 Dec 2025 | 30,964 | 258,787 (0%) | 0% | 75.2 | 2,326,945 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 74.60 per share. | 12 Dec 2025 | 28,311 | 230,476 (0%) | 0% | 74.6 | 2,111,992 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 75.24 per share. | 12 Dec 2025 | 1,700 | 228,776 (0%) | 0% | 75.2 | 127,910 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 73.05 per share. | 04 Dec 2025 | 12,517 | 763,169 (0%) | 0% | 73.0 | 914,324 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 73.04 per share. | 04 Dec 2025 | 12,288 | 4,566,159 (3%) | 0% | 73.0 | 897,529 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 74.42 per share. | 04 Dec 2025 | 12,200 | 4,584,147 (3%) | 0% | 74.4 | 907,970 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 74.42 per share. | 04 Dec 2025 | 12,192 | 781,394 (0%) | 0% | 74.4 | 907,381 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 73.75 per share. | 04 Dec 2025 | 7,712 | 4,558,447 (3%) | 0% | 73.7 | 568,758 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 73.76 per share. | 04 Dec 2025 | 7,483 | 755,686 (0%) | 0% | 73.8 | 551,951 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 74.80 per share. | 04 Dec 2025 | 5,708 | 775,686 (0%) | 0% | 74.8 | 426,939 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 74.80 per share. | 04 Dec 2025 | 5,700 | 4,578,447 (3%) | 0% | 74.8 | 426,358 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 73.16 per share. | 04 Dec 2025 | 2,100 | 793,586 (0%) | 0% | 73.2 | 153,638 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 73.16 per share. | 04 Dec 2025 | 2,100 | 4,596,347 (3%) | 0% | 73.2 | 153,626 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 65.90 per share. | 20 Nov 2025 | 14,299 | 234,232 (0%) | 0% | 65.9 | 942,361 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 64.97 per share. | 20 Nov 2025 | 6,401 | 248,531 (0%) | 0% | 65.0 | 415,877 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 66.71 per share. | 20 Nov 2025 | 5,456 | 228,776 (0%) | 0% | 66.7 | 363,986 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2025 | 33,544 | 256,634 (0%) | 0% | - | Common Stock | |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2025 | 33,544 | 167,720 | - | - | Restricted Stock Units | |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.39 per share. | 16 Nov 2025 | 32,855 | 254,932 (0%) | 0% | 66.4 | 2,181,243 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2025 | 19,599 | 276,233 (0%) | 0% | - | Common Stock | |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2025 | 19,599 | 176,394 | - | - | Restricted Stock Units | |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2025 | 11,554 | 287,787 (0%) | 0% | - | Common Stock | |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2025 | 11,554 | 150,199 | - | - | Restricted Stock Units | |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 62.91 per share. | 06 Nov 2025 | 12,576 | 4,625,871 (3%) | 0% | 62.9 | 791,166 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 62.91 per share. | 06 Nov 2025 | 12,529 | 823,157 (0%) | 0% | 62.9 | 788,184 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 61.14 per share. | 06 Nov 2025 | 12,492 | 4,605,955 (3%) | 0% | 61.1 | 763,762 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 61.13 per share. | 06 Nov 2025 | 12,234 | 803,452 (0%) | 0% | 61.1 | 747,862 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 61.87 per share. | 06 Nov 2025 | 7,546 | 795,906 (0%) | 0% | 61.9 | 466,839 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 63.56 per share. | 06 Nov 2025 | 7,371 | 815,786 (0%) | 0% | 63.6 | 468,472 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 63.55 per share. | 06 Nov 2025 | 7,324 | 4,618,547 (3%) | 0% | 63.5 | 465,416 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 61.87 per share. | 06 Nov 2025 | 7,308 | 4,598,647 (3%) | 0% | 61.9 | 452,156 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 62.80 per share. | 06 Nov 2025 | 220 | 795,686 (0%) | 0% | 62.8 | 13,815 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 62.80 per share. | 06 Nov 2025 | 200 | 4,598,447 (3%) | 0% | 62.8 | 12,561 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 64.39 per share. | 06 Nov 2025 | 100 | 815,686 (0%) | 0% | 64.4 | 6,439 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 64.39 per share. | 06 Nov 2025 | 100 | 4,618,447 (3%) | 0% | 64.4 | 6,439 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 54.80 per share. | 08 Oct 2025 | 20,000 | 835,686 (0%) | 0% | 54.8 | 1,096,046 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 54.80 per share. | 08 Oct 2025 | 20,000 | 4,638,447 (3%) | 0% | 54.8 | 1,096,046 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 55.09 per share. | 08 Oct 2025 | 11,295 | 855,686 (0%) | 0% | 55.1 | 622,226 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 55.09 per share. | 08 Oct 2025 | 11,294 | 4,658,447 (3%) | 0% | 55.1 | 622,171 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 54.39 per share. | 08 Oct 2025 | 8,706 | 4,669,741 (3%) | 0% | 54.4 | 473,504 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 54.39 per share. | 08 Oct 2025 | 8,705 | 866,981 (0%) | 0% | 54.4 | 473,450 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 53.16 per share. | 04 Sep 2025 | 16,900 | 876,486 (0%) | 0% | 53.2 | 898,450 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 53.16 per share. | 04 Sep 2025 | 16,800 | 4,679,347 (3%) | 0% | 53.2 | 893,125 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 51.16 per share. | 04 Sep 2025 | 14,558 | 901,128 (0%) | 0% | 51.2 | 744,739 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 51.15 per share. | 04 Sep 2025 | 14,525 | 4,703,922 (3%) | 0% | 51.2 | 742,960 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 51.85 per share. | 04 Sep 2025 | 5,475 | 4,698,447 (3%) | 0% | 51.9 | 283,902 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 51.85 per share. | 04 Sep 2025 | 5,442 | 895,686 (0%) | 0% | 51.9 | 282,187 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 51.96 per share. | 04 Sep 2025 | 2,300 | 893,386 (0%) | 0% | 52.0 | 119,514 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 51.95 per share. | 04 Sep 2025 | 2,300 | 4,696,147 (3%) | 0% | 52.0 | 119,496 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 53.80 per share. | 04 Sep 2025 | 900 | 4,678,447 (3%) | 0% | 53.8 | 48,424 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 53.80 per share. | 04 Sep 2025 | 800 | 875,686 (0%) | 0% | 53.8 | 43,040 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 48.81 per share. | 20 Aug 2025 | 25,728 | 223,518 (0%) | 0% | 48.8 | 1,255,848 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 49.25 per share. | 20 Aug 2025 | 428 | 223,090 (0%) | 0% | 49.3 | 21,079 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2025 | 64,697 | 282,101 (0%) | 0% | - | Common Stock | |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2025 | 33,544 | 201,264 | - | - | Restricted Stock Units | |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.32 per share. | 16 Aug 2025 | 32,855 | 249,246 (0%) | 0% | 51.3 | 1,686,119 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2025 | 19,599 | 195,993 | - | - | Restricted Stock Units | |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2025 | 11,554 | 161,753 | - | - | Restricted Stock Units | |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 45.64 per share. | 07 Aug 2025 | 13,216 | 4,738,447 (3%) | 0% | 45.6 | 603,152 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 45.64 per share. | 07 Aug 2025 | 13,216 | 935,686 (0%) | 0% | 45.6 | 603,152 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 45.88 per share. | 07 Aug 2025 | 11,795 | 923,891 (0%) | 0% | 45.9 | 541,162 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 45.88 per share. | 07 Aug 2025 | 11,795 | 4,726,652 (3%) | 0% | 45.9 | 541,162 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 46.71 per share. | 07 Aug 2025 | 8,205 | 915,686 (0%) | 0% | 46.7 | 383,252 | Common Stock |